Form 4: Alan Grujic Reports Acquisition of Shares in Guided Therapeutics Inc.
SEC Form 4
Director Alan Grujic acquired 36,602 shares of Guided Therapeutics Inc. common stock due to accrued dividends on Series E preferred stock.
Summary
- On August 21, 2024, Alan Grujic, a director of Guided Therapeutics Inc., acquired 36,602 shares of common stock.
- The acquisition was a result of accrued dividends on the reporting individual's Series E preferred stock.
- The conversion price for these shares was $0.1093.
- Following the transaction, Grujic directly owns 1,448,025 shares of Guided Therapeutics Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a transaction. It doesn't inherently convey positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/21/2024 | Date of transaction: Alan Grujic acquired shares of common stock. |
| 08/23/2024 | Date of signature for the report. |
Keywords
Guided Therapeutics Inc., Alan Grujic, share acquisition, Form 4, director, dividends, Series E preferred stock, GTHP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.